<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lamin V</submitter><funding>NIA NIH HHS</funding><funding>NHLBI NIH HHS</funding><pagination>e025727</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9496313</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(16)</volume><pubmed_abstract>Background Peripheral artery disease is caused by atherosclerotic occlusion of vessels outside the heart and most commonly affects vessels of the lower extremities. Angiogenesis is a part of the postischemic adaptation involved in restoring blood flow in peripheral artery disease. Previously, in a murine hind limb ischemia model of peripheral artery disease, we identified ADAM12 (a disintegrin and metalloproteinase gene 12) as a key genetic modifier of postischemic perfusion recovery. However, less is known about ADAM12 regulation in ischemia. MicroRNAs are a class of small, noncoding, single-stranded RNAs that regulate gene expression primarily through transcriptional repression of messenger RNA (mRNA). We showed microRNA-29a (miR-29a) modulates ADAM12 expression in the setting of diabete</pubmed_abstract><journal>Journal of the American Heart Association</journal><pubmed_title>microRNA-29a Regulates ADAM12 Through Direct Interaction With ADAM12 mRNA and Modulates Postischemic Perfusion Recovery.</pubmed_title><pmcid>PMC9496313</pmcid><funding_grant_id>R56 AG063820</funding_grant_id><funding_grant_id>R01 HL130399</funding_grant_id><pubmed_authors>Wong T</pubmed_authors><pubmed_authors>Lamin V</pubmed_authors><pubmed_authors>Kronemberger A</pubmed_authors><pubmed_authors>Dokun OS</pubmed_authors><pubmed_authors>Lira VA</pubmed_authors><pubmed_authors>Dokun AO</pubmed_authors><pubmed_authors>Verry J</pubmed_authors></additional><is_claimable>false</is_claimable><name>microRNA-29a Regulates ADAM12 Through Direct Interaction With ADAM12 mRNA and Modulates Postischemic Perfusion Recovery.</name><description>Background Peripheral artery disease is caused by atherosclerotic occlusion of vessels outside the heart and most commonly affects vessels of the lower extremities. Angiogenesis is a part of the postischemic adaptation involved in restoring blood flow in peripheral artery disease. Previously, in a murine hind limb ischemia model of peripheral artery disease, we identified ADAM12 (a disintegrin and metalloproteinase gene 12) as a key genetic modifier of postischemic perfusion recovery. However, less is known about ADAM12 regulation in ischemia. MicroRNAs are a class of small, noncoding, single-stranded RNAs that regulate gene expression primarily through transcriptional repression of messenger RNA (mRNA). We showed microRNA-29a (miR-29a) modulates ADAM12 expression in the setting of diabete</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-04T12:04:35.338Z</modification><creation>2025-04-04T12:04:35.338Z</creation></dates><accession>S-EPMC9496313</accession><cross_references><pubmed>35946473</pubmed><doi>10.1161/JAHA.122.025727</doi></cross_references></HashMap>